AU2003220968A1 - Anti-inflammatory agent - Google Patents

Anti-inflammatory agent

Info

Publication number
AU2003220968A1
AU2003220968A1 AU2003220968A AU2003220968A AU2003220968A1 AU 2003220968 A1 AU2003220968 A1 AU 2003220968A1 AU 2003220968 A AU2003220968 A AU 2003220968A AU 2003220968 A AU2003220968 A AU 2003220968A AU 2003220968 A1 AU2003220968 A1 AU 2003220968A1
Authority
AU
Australia
Prior art keywords
anti
inflammatory agent
inflammatory
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003220968A
Inventor
Hitoshi Arai
Miho Iwase
Ari Kawanabe
Katsuya Kobayashi
Daisuke Machii
Ichiro Miki
Etsuo Ohshima
Takashi Sato
Yosuke Yamaura
Koji Yanagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Hakko Kogyo Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2002-90640 priority Critical
Priority to JP2002090640 priority
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Priority to PCT/JP2003/004009 priority patent/WO2003082855A1/en
Publication of AU2003220968A1 publication Critical patent/AU2003220968A1/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
AU2003220968A 2002-03-28 2003-03-28 Anti-inflammatory agent Abandoned AU2003220968A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2002-90640 2002-03-28
JP2002090640 2002-03-28
PCT/JP2003/004009 WO2003082855A1 (en) 2002-03-28 2003-03-28 Anti-inflammatory agent

Publications (1)

Publication Number Publication Date
AU2003220968A1 true AU2003220968A1 (en) 2003-10-13

Family

ID=28671664

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003220968A Abandoned AU2003220968A1 (en) 2002-03-28 2003-03-28 Anti-inflammatory agent

Country Status (3)

Country Link
JP (1) JPWO2003082855A1 (en)
AU (1) AU2003220968A1 (en)
WO (1) WO2003082855A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2332924A1 (en) 2001-10-17 2011-06-15 Boehringer Ingelheim Pharma GmbH & Co. KG Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
AU2003288994A1 (en) 2002-12-10 2004-06-30 Ono Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic compounds and medicinal use thereof
WO2005082865A1 (en) * 2004-02-27 2005-09-09 Astellas Pharma Inc. Fused bicyclic pyrimidine derivative
KR20070107046A (en) * 2005-02-16 2007-11-06 쉐링 코포레이션 Heterocyclic substituted piperazines with cxcr3 antagonist activity
CN101203509B (en) * 2005-02-16 2013-05-08 默沙东公司 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
JP5118029B2 (en) * 2005-06-14 2013-01-16 タイゲン バイオテクノロジー カンパニー,リミテッド Pyrimidine compounds
CN101242848B (en) 2005-06-14 2011-12-21 太景生物科技股份有限公司 Pyrimidine compound
US8193206B2 (en) 2005-06-14 2012-06-05 Taigen Biotechnology Co., Ltd. Pyrimidine compounds
CA2673231A1 (en) * 2006-12-22 2008-07-03 Schering Corporation Heterocyclic compounds with cxcr3 antagonist activity
GB201017345D0 (en) * 2010-10-14 2010-11-24 Proximagen Ltd Receptor antagonists
US9139534B2 (en) 2011-04-22 2015-09-22 Signal Pharmaceuticals, Llc Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
AU2016244228B2 (en) * 2011-04-22 2019-02-21 Signal Pharmaceuticals, Llc Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
EP3082819A4 (en) 2013-12-20 2017-08-23 Signal Pharmaceuticals, LLC Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
NZ715903A (en) 2014-01-30 2017-06-30 Signal Pharm Llc Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
JP2018500560A (en) 2014-12-16 2018-01-11 シグナル ファーマシューティカルズ,エルエルシー Method for measuring inhibition of c-Jun N-terminal kinase in skin
CN107108524A (en) 2014-12-16 2017-08-29 西格诺药品有限公司 The formulation of the formamide of 2 (tert-butylamino) 4 (the methylcyclohexyl amino of (1R, 3R, 4R) 3 hydroxyl 4) pyrimidine 5
MX2018001004A (en) 2015-07-24 2018-06-07 Celgene Corp Methods of synthesis of (1r,2r,5r)-5-amino-2-methylcyclohexanol hydrochloride and intermediates useful therein.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6498161B1 (en) * 1999-04-06 2002-12-24 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
SE9904738D0 (en) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
WO2003082855A1 (en) 2003-10-09
JPWO2003082855A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
AU2003298738A1 (en) Liposomal formulations
AU2003218461A1 (en) Improved stent
AU2003218123A1 (en) Shaped tampon
AU2003210921A1 (en) Orthosontic adhesives
AU2002327094A1 (en) Cosmetics
AU2003222841A1 (en) Phenethanolamine derivatives
AU2003293632A1 (en) Phenethanolamine derivatives
AU2003216002A1 (en) Efficient mmicrofluidic devices
AU2003244672A1 (en) Positioning technique
AU2003235759A1 (en) 4-dedimethylamino tetracycline compounds
AU2003302139A1 (en) Aluminum-zinc-magnesium-copper alloy extrusion
AU2003220935A1 (en) Benzamide derivatives
AU2003243226A1 (en) Vitamin-mitomycin conjugates
AU2003284352A1 (en) Pentafluoropropene-based compositions
AU2003262785A1 (en) Toilet assembly
AU2003266949A1 (en) Compounds
AU2003233465A1 (en) Structural member
AU2003242381A1 (en) Radar
AU2003237944A1 (en) Abuse-protected administration form
AU2003229211A1 (en) Underreamer
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003253043A1 (en) Catheter
AU2003296572A1 (en) Endoscope
AU2003291103A1 (en) Pharmaceutical composition
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase